Global Gene Delivery System Market Witnessed to Surge Rapidly at a Remarkable CAGR of 7.8% during forecast 2017 – 2025

Published on : Apr 30, 2018

Albany, New York, April 30, 2018: Scientists have built upon various discoveries regarding the effect of genes in the detection and treatment of various chronic diseases. A new report suggests that increases in the incidence of chronic diseases, the rise in technological advancement in administration of drug delivery are projected to boost the market for drug delivery system in the future. Market Research Hub (MRH) has publicized a study titled “Gene Delivery System Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025” to its massive online repository, which encloses useful information about the trends, factors, regions and market growth in a precise manner. Moreover, the report covers market dynamics including drivers, restraints opportunities, and trends expected to influence the global gene delivery system market growth during the said period.

Geographically, the research identifies opportunities present in the market on the basis of a regional analysis which highlights Asia-Pacific excluding Japan, Latin America, Japan, Middle East & Africa, Europe, and North America. The market size and forecast for each region have been provided for the period from 2015 to 2025, along with their respective CAGRs. According to the research findings, the global gene delivery system market was valued approximately US$ 2,227.8 Mn in 2016 and is anticipated to expand at a CAGR of over 7.8% from 2017 to 2025 to reach a value of nearly US$ 4,281.0 Mn by 2025.

Factors Fueling Market Growth

Gene delivery systems are used to deliver therapeutic drugs targeting a specific area. Presently, increase in need for advanced technologies for targeted systems are rapidly prompting the market growth of gene delivery systems. Apart from that, rise in demand for targeted and low dose frequency drug delivery, increase in investment in research & development, surge in demand for self-administration devices for home health care, and increase in the prevalence of chronic life-threatening diseases are driving the global gene delivery system market.

In terms of geography, the report finds that rise in prevalence of chronic diseases in the U.S. and Europe and technological advancement in drug delivery systems are driving the gene delivery market in North America. Besides, the market in the Asia Pacific is projected to expand at a rapid pace due to rise in investment of key players in this region.

The report also analyses market growth by dividing the global market into prime segments, such as the type of delivery system, application, and route of administration. Based on delivery system the global gene delivery system market is segmented into viral gene delivery system, non-viral gene delivery system, and combined hybrid system. Major applications include infectious diseases, oncology, ophthalmology, urology, diabetes, CNS, and others. Of them, the oncology segment dominates the market.

In the end, major companies functioning in the global gene delivery system market are profiled. They are Bayer AG, Novartis AG, Amgen Inc., Johnson & Johnson Services Inc., Human Stem Cells Institute, Oxford BioMedia plc, SIBIONO, Shanghai Sunway Biotech Co. Ltd., Pfizer Inc., and Epeius Biotechnologies Corporation.

Request a Sample with TOC in a PDF format :

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email :

Back To Top